Literature DB >> 26935241

Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.

Nicolas Duployez1,2, Olivier Nibourel3,4, Benoît Ducourneau3, Nathalie Grardel3, Thomas Boyer3,4, Claire Bories5, Stéphane Darre6, Valérie Coiteux5, Céline Berthon4,5, Claude Preudhomme3,4, Catherine Roche-Lestienne4,7.   

Abstract

We report a case of myeloproliferative neoplasm (MPN) with an atypical t(9;22;15)(p24;q11;q21) translocation, leading to a BCR-JAK2 fusion, associated with a trisomy of chromosome 8 in clonal evolution at karyotype. Patient's evolution was marked by an aggressive clinical course with rapid progression to blast phase within the first year after diagnosis. Examination of matched chronic phase and blast crisis samples by SNP-array karyotyping identified secondary acquired cryptic genetic events at the time of lymphoblastic transformation, including biallelic IKZF1 alteration and EBF1 and CDKN2A/B codeletions. This case is the first report describing acquisition of secondary genetic events leading to acute lymphoblastic progression in a rare MPN with BCR-JAK2 fusion.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BCR-JAK2; IKZF1; SNP-array; acute leukemia; cytogenetics; myeloproliferative neoplasms

Mesh:

Substances:

Year:  2016        PMID: 26935241     DOI: 10.1111/ejh.12752

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

1.  Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance.

Authors:  Justin Anthony Chen; Yanli Hou; Krishna M Roskin; Daniel A Arber; Charles D Bangs; Linda B Baughn; Athena M Cherry; Mark D Ewalt; Andrew Z Fire; Laure Fresard; Hutton M Kearney; Stephen B Montgomery; Robert S Ohgami; Kathryn E Pearce; Beth A Pitel; Jason D Merker; Jason Gotlib
Journal:  Blood Adv       Date:  2021-09-14

2.  COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.

Authors:  Bruno Almeida Lopes; Claus Meyer; Thayana Conceição Barbosa; Udo Zur Stadt; Martin Horstmann; Nicola C Venn; Susan Heatley; Deborah L White; Rosemary Sutton; Maria S Pombo-de-Oliveira; Rolf Marschalek; Mariana Emerenciano
Journal:  Oncotarget       Date:  2016-08-16

3.  IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia.

Authors:  Bruno A Lopes; Claus Meyer; Thayana C Barbosa; Caroline P Poubel; Marcela B Mansur; Nicolas Duployez; Matthew Bashton; Christine J Harrison; Udo Zur Stadt; Martin Horstmann; Maria S Pombo-de-Oliveira; Chiara Palmi; Gianni Cazzaniga; Nicola C Venn; Rosemary Sutton; Cristina N Alonso; Grigory Tsaur; Sanjeev K Gupta; Sameer Bakhshi; Rolf Marschalek; Mariana Emerenciano
Journal:  Transl Oncol       Date:  2019-03-13       Impact factor: 4.243

4.  Haemophagocytic syndrome triggered by acute lymphoblastic leukaemia with t(9;22)(p24; q11.2).

Authors:  Huiling Chen; Pengyun Zeng; Dekui Zhang
Journal:  J Int Med Res       Date:  2019-09-18       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.